Cite

    Constantine, G. et al. (2018). Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data. Current medical research and opinion. pp. 2131-2136. [Online].